Gastrointestinal Endoscopy
Volume 71, Issue 3 , Pages 560-572, March 2010

Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors

Current affiliations: Department of Medicine (A.J.S.), Weill Medical College of Cornell University, New York, New York, Miles and Shirley Fiterman Center for Digestive Diseases (N.C.-P., T.H.B.), Mayo Clinic, Rochester, Minnesota, USA

Received 13 July 2009; accepted 8 October 2009.

Rochester, Minnesota, USA

Background

Self-expandable metal stents (SEMSs) are used for colonic obstruction palliatively and preoperatively.

Objective

Determine long-term efficacy, incidence of complications, and risk factors of SEMS placement for colonic obstruction.

Design

Retrospective review of SEMSs placed for malignant colorectal obstruction from 1999 to 2008.

Setting

Tertiary-care center.

Patients

This study involved 168 patients who underwent SEMS placement for palliation and 65 patients who underwent SEMS placement as a “bridge to surgery.”

Intervention

Colonic SEMS placement.

Main Outcome Measurements

Stricture location, stent-induced complications, time to adverse events, need for reintervention.

Results

Technical and immediate clinical success rates were 96% and 99% in the palliative group and 95% and 98% in the preoperative group. Forty-one patients (24.4%) in the palliative group had complications including perforation (9%), occlusion (9%), migration (5%), and erosion/ulcer (2%). Mean stent patency was 145 days in the palliative group. One hundred eight of 122 patients (88.5%) were free of obstruction from implantation until death. Preoperatively placed stents remained in situ for a mean of 25.4 days and remained patent until surgery in 73.8% of patients. Complications were present preoperatively in 23.1% of patients; 94% underwent elective colectomy. Univariate analysis identified males, complete obstruction, stent diameter ≤22 mm, stricture dilation during SEMS insertion, and operator experience as significant risk factors for complication. In the palliative group, intraluminal lesions (27% vs 19%), bevacizumab (35% vs 23%), and distal colon placement of the stent (27% vs 13%) were also associated with higher complication rates as compared to extraluminal lesions, patients not treated with bevacizumab, and stents in the proximal colon, respectively. Bevacizumab therapy nearly tripled the risk of perforation.

Limitations

Retrospective analysis, single institution.

Conclusion

Colorectal SEMS placement is relatively safe and effective but with a complication rate of nearly 25%. Patient characteristics and technical variables appear to affect the outcome of SEMS therapy.

Abbreviations: SEMSs, self-expandable metal stents

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.

 See CME section; p. 596

 If you would like to chat with an author of this article, you may contact Dr. Baron at baron.todd@mayo.edu.

PII: S0016-5107(09)02575-9

doi:10.1016/j.gie.2009.10.012

Gastrointestinal Endoscopy
Volume 71, Issue 3 , Pages 560-572, March 2010